This clinical trial study is conducted in Vietnam to assess the efficacy and tolerability of Proteoglycan F in the treatment of primary knee osteoarthritis. 72 outpatients (40-80 years old) were diagnosed with primary knee osteoarthritis and met the American College of Rheumatology 1991 criteria. Patients have to be symptomatic for ≥ 3 months before enrollment and have a radiologic grade II and III measured by the Kellgren-Lawrence criteria. The study was designed as a Prospective, Randomized, Double-blind Controlled trial. Each patient will be follow during 24 weeks of intervention, follow-up every 4 weeks.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pain relief
Timeframe: 6 month
Reduce symptoms of knee osteoarthritis 1
Timeframe: 6 month
Reduce symptoms of knee osteoarthritis 2
Timeframe: 6 month
Reduce symptoms of knee osteoarthritis 3
Timeframe: 6 month
Changes of balance, walking ability and functional mobility
Timeframe: 6 month
Changes of knee joint status
Timeframe: 6 month
The transverse relaxation time (T2) of the cartilage and Classification of other knee injuries
Timeframe: 6 month